drugset / Trial / NCT06653556
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
Phase 0
Recruiting
34 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Beijing GoBroad Hospital · collabNanjing Legend Biotech Co. · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, single-arm, open-label, dose-exploration and expansion clinical study of LCAR-AIO in adult subjects with relapsed/refractory systemic lupus erythematosus.
Timeline
- Start
- 2025-01-08
- Primary completion
- 2027-09-30
- Completion
- 2029-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LCAR-AIO | Cell therapy | — | Other |